4.7 Article

RapGEF2 is essential for embryonic hematopoiesis but dispensable for adult hematopoiesis

期刊

BLOOD
卷 116, 期 16, 页码 2921-2931

出版社

AMER SOC HEMATOLOGY
DOI: 10.1182/blood-2010-01-262964

关键词

-

资金

  1. National Institutes of Health (NIH), NCI, Center for Cancer Research

向作者/读者索取更多资源

RapGEF2 is one of many guanine nucleotide exchange factors (GEFs) that specifically activate Rap1. Here, we generated RapGEF2 conditional knockout mice and studied its role in embryogenesis and fetal as well as adult hematopoietic stem cell (HSC) regulation. RapGEF2 deficiency led to embryonic lethality at similar to E11.5 due to severe yolk sac vascular defects. However, a similar number of Flk1(+) cells were present in RapGEF2(+/+) and RapGEF2(-/-) yolk sacs indicating that the bipotential early progenitors were in fact generated in the absence of RapGEF2. Further analysis of yolk sacs and embryos revealed a significant reduction of CD41 expressing cells in RapGEF2(-/-) genotype, suggesting a defect in the maintenance of definitive hematopoiesis. RapGEF2(-/-) cells displayed defects in proliferation and migration, and the in vitro colony formation ability of hematopoietic progenitors was also impaired. At the molecular level, Rap1 activation was impaired in RapGEF2(-/-) cells that in turn lead to defective B-raf/ERK signaling. Scl/Gata transcription factor expression was significantly reduced, indicating that the defects observed in RapGEF2(-/-) cells could be mediated through Scl/Gata deregulation. Inducible deletion of RapGEF2 during late embryogenesis in RapGEF2(cko/cko)ER(cre) mice leads to defective fetal liver erythropoiesis. Conversely, inducible deletion in the adult bone marrow, or specific deletion in B cells, T cells, HSCs, and endothelial cells has no impact on hematopoiesis. (Blood.2010;116(16):2921-2931)

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Multidisciplinary Sciences

Tagging enhances histochemical and biochemical detection of Ran Binding Protein 9 in vivo and reveals its interaction with Nucleolin

Shimaa H. A. Soliman, Aaron E. Stark, Miranda L. Gardner, Sean W. Harshman, Chelssie C. Breece, Foued Amari, Arturo Orlacchio, Min Chen, Anna Tessari, Jennifer A. Martin, Rosa Visone, Michael A. Freitas, Krista M. D. La Perle, Dario Palmieri, Vincenzo Coppola

SCIENTIFIC REPORTS (2020)

Article Oncology

Recurrent XPO1 mutations alter pathogenesis of chronic lymphocytic leukemia

Janek S. Walker, Zachary A. Hing, Bonnie Harrington, Jordan Baumhardt, Hatice Gulcin Ozer, Amy Lehman, Brian Giacopelli, Larry Beaver, Katie Williams, Jordan N. Skinner, Casey B. Cempre, Qingxiang Sun, Sharon Shacham, Benjamin R. Stromberg, Matthew K. Summers, Lynne Abruzzo, Laura Rassenti, Thomas J. Kipps, Sameer Parikh, Neil E. Kay, Kerry A. Rogers, Jennifer A. Woyach, Vincenzo Coppola, Yuh Min Chook, Christopher Oakes, John C. Byrd, Rosa Lapalombella

Summary: Mutations in XPO1 at E571 are associated with high-risk genetic and epigenetic features as well as accelerated progression in CLL. Overexpression of wt or mutant XPO1 in B cells can impact the development of CLL-like disease in aged mice. Concurrent expression of XPO1 with E571K or E571G mutations and TCL1 accelerates leukemogenesis.

JOURNAL OF HEMATOLOGY & ONCOLOGY (2021)

Article Multidisciplinary Sciences

Targeting OCT3 attenuates doxorubicin-induced cardiac injury

Kevin M. Huang, Megan Zavorka Thomas, Tarek Magdy, Eric D. Eisenmann, Muhammad Erfan Uddin, Duncan F. DiGiacomo, Alexander Pan, Markus Keiser, Marcus Otter, Sherry H. Xia, Yang Li, Yan Jin, Qiang Fu, Alice A. Gibson, Ingrid M. Bonilla, Cynthia A. Carnes, Kara N. Corps, Vincenzo Coppola, Sakima A. Smith, Daniel Addison, Anne T. Nies, Ralf Bundschuh, Taosheng Chen, Maryam B. Lustberg, Joanne Wang, Stefan Oswald, Moray J. Campbell, Pearlly S. Yan, Sharyn D. Baker, Shuiying Hu, Paul W. Burridge, Alex Sparreboom

Summary: By studying the critical transporter OCT3 for doxorubicin accumulation in the heart, researchers have revealed the mechanism of doxorubicin-induced cardiotoxicity, providing a theoretical basis for a targeted intervention strategy to prevent this side effect.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2021)

Article Oncology

MYBL2-Driven Transcriptional Programs Link Replication Stress and Error-prone DNA Repair With Genomic Instability in Lung Adenocarcinoma

Benjamin B. Morris, Nolan A. Wages, Patrick A. Grant, P. Todd Stukenberg, Ryan D. Gentzler, Richard D. Hall, Wallace L. Akerley, Thomas K. Varghese, Susanne M. Arnold, Terence M. Williams, Vincenzo Coppola, David R. Jones, David T. Auble, Marty W. Mayo

Summary: Evidence suggests that many patients with lung adenocarcinoma exhibit significant genome instability and overexpress the transcription factor MYBL2, which is associated with poor prognostic outcomes and potential disruption of DNA repair pathways.

FRONTIERS IN ONCOLOGY (2021)

Article Endocrinology & Metabolism

Hepatocyte-specific PKC beta deficiency protects against high-fat diet-induced nonalcoholic hepatic steatosis

Yaoling Shu, Faizule Hassan, Vincenzo Coppola, Kedryn K. Baskin, Xianlin Han, Neil K. Mehta, Michael C. Ostrowski, Kamal D. Mehta

Summary: Protein kinase C beta (PKC beta) plays a critical role in energy metabolism and adaptation to environmental and nutritional stimuli, particularly in the development of hepatic steatosis induced by high-fat diet. The hepatocyte-specific PKC beta deficiency offers protection against hepatic steatosis without affecting insulin sensitivity.

MOLECULAR METABOLISM (2021)

Article Multidisciplinary Sciences

被撤回的出版物: AKT3-mediated IWS1 phosphorylation promotes the proliferation of EGFR-mutant lung adenocarcinomas through cell cycle-regulated U2AF2 RNA splicing (Retracted article. See vol. 13, 2022)

Georgios I. Laliotis, Evangelia Chavdoula, Maria D. Paraskevopoulou, Abdul Kaba, Alessandro La Ferlita, Satishkumar Singh, Vollter Anastas, Keith A. Nair, Arturo Orlacchio, Vasiliki Taraslia, Ioannis Vlachos, Marina Capece, Artemis Hatzigeorgiou, Dario Palmieri, Christos Tsatsanis, Salvatore Alaimo, Lalit Sehgal, David P. Carbone, Vincenzo Coppola, Philip N. Tsichlis

Summary: AKT-phosphorylated IWS1 regulates alternative RNA splicing in lung cancer, leading to the growth of lung adenocarcinomas via a Sororin/ERK-dependent pathway. The activity of this pathway is associated with clinical characteristics and prognosis of the tumors.

NATURE COMMUNICATIONS (2021)

Article Multidisciplinary Sciences

Rare t(X;14)(q28;q32) translocation reveals link between MTCP1 and chronic lymphocytic leukemia

Janek S. Walker, Zachary A. Hing, Steven Sher, James Cronin, Katie Williams, Bonnie Harrington, Jordan N. Skinner, Casey B. Cempre, Charles T. Gregory, Alexander Pan, Max Yano, Larry P. Beaver, Brandi R. Walker, Jadwiga M. Labanowska, Nyla A. Heerema, Krzysztof Mrozek, Jennifer A. Woyach, Amy S. Ruppert, Amy Lehman, Hatice Gulcin Ozer, Vincenzo Coppola, Pearlly Yan, John C. Byrd, James S. Blachly, Rosa Lapalombella

Summary: Some balanced translocations can drive tumourigenesis, with MTCP1 identified as a driver gene in chronic lymphocytic leukemia. Overexpression of MTCP1 in mice leads to disease, highlighting the importance of genetic interrogation to identify cancer-driving genes. Discovery of MTCP1's role in CLL pathogenesis reinforces the need for further investigation of rare, recurrent balanced translocations.

NATURE COMMUNICATIONS (2021)

Article Biology

Phosphor-IWS1-dependent U2AF2 splicing regulates trafficking of CAR-E-positive intronless gene mRNAs and sensitivity to viral infection

Georgios I. Laliotis, Adam D. Kenney, Evangelia Chavdoula, Arturo Orlacchio, Abdul Kaba, Alessandro La Ferlita, Vollter Anastas, Christos Tsatsanis, Joal D. Beane, Lalit Sehgal, Vincenzo Coppola, Jacob S. Yount, Philip N. Tsichlis

Summary: AKT-phosphorylated IWS1 promotes the alternative splicing of U2AF2, leading to regulation of mRNA nuclear export, including those encoding Type I interferons. This pathway affects sensitivity to multiple cytolytic virus infections, and may serve as a potential therapeutic target in cancer treatment.

COMMUNICATIONS BIOLOGY (2021)

Article Multidisciplinary Sciences

Enhanced BRAF engagement by NRAS mutants capable of promoting melanoma initiation

Brandon M. Murphy, Elizabeth M. Terrell, Venkat R. Chirasani, Tirzah J. Weiss, Rachel E. Lew, Andrea M. Holderbaum, Aastha Dhakal, Valentina Posada, Marie Fort, Michael S. Bodnar, Leiah M. Carey, Min Chen, Craig J. Burd, Vincenzo Coppola, Deborah K. Morrison, Sharon L. Campbell, Christin E. Burd

Summary: In this study, the authors use conditional mouse models to investigate the molecular mechanisms underlying the enrichment of specific NRAS mutants in human melanoma. They find that different tumor types exhibit distinct profiles of NRAS mutants, suggesting mutagenic events or functional differences may contribute to the profiles. The study also identifies molecular interactions that enhance the binding affinity of melanomagenic NRAS mutants and their signaling pathways.

NATURE COMMUNICATIONS (2022)

Meeting Abstract Hematology

Constitutive PRMT5 Expression Drives Spontaneous Lymphoblastic Lymphoma In Vivo

Lynda Villagomez, Porsha Smith, Fengting Yan, Victor Chen, Shelby Sloan, John T. Patton, Mackenzie Long, Fiona Brown, Elshafa H. Ahmed, Natarajan Muthusamy, Vincenzo Coppola, Anjali Mishra, Kris Vaddi, Peggy Scherle, Rosa Lapalombella, Lapo Alinari, Robert A. Baiocchi

Article Multidisciplinary Sciences

Dysregulation of PRMT5 in chronic lymphocytic leukemia promotes progression with high risk of Richter's transformation

Zachary A. Hing, Janek S. Walker, Ethan C. Whipp, Lindsey Brinton, Matthew Cannon, Pu Zhang, Steven Sher, Casey B. Cempre, Fiona Brown, Porsha L. Smith, Claudio Agostinelli, Stefano A. Pileri, Jordan N. Skinner, Katie Williams, Hannah Phillips, Jami Shaffer, Larry P. Beaver, Alexander Pan, Kyle Shin, Charles T. Gregory, Gulcin H. Ozer, Selen A. Yilmaz, Bonnie K. Harrington, Amy M. Lehman, Lianbo Yu, Vincenzo Coppola, Pearlly Yan, Peggy Scherle, Min Wang, Philip Pitis, Chaoyi Xu, Kris Vaddi, Selina Chen-Kiang, Jennifer Woyach, James S. Blachly, Lapo Alinari, Yiping Yang, John C. Byrd, Robert A. Baiocchi, Bradley W. Blaser, Rosa Lapalombella

Summary: PRMT5 plays an important role in the progression of CLL to Richter transformation, and the PRMT5 inhibitor PRT382 shows potential therapeutic value.

NATURE COMMUNICATIONS (2023)

Review Oncology

Role of Mitochondrial Transporters on Metabolic Rewiring of Pancreatic Adenocarcinoma: A Comprehensive Review

Graziantonio Lauria, Rosita Curcio, Paola Lunetti, Stefano Tiziani, Vincenzo Coppola, Vincenza Dolce, Giuseppe Fiermonte, Amer Ahmed

Summary: Pancreatic ductal adenocarcinoma (PDAC) extensively rewires its metabolism to utilize glucose and glutamine for nucleotide and protein synthesis, lipid synthesis, and redox homeostasis. Several mitochondrial transporters play a crucial role in this metabolic rewiring, and targeting them may be a potential strategy for combating PDAC.

CANCERS (2023)

Article Biochemistry & Molecular Biology

Generation of a Yeast Cell Model Potentially Useful to Identify the Mammalian Mitochondrial N-Acetylglutamate Transporter

Ruggiero Gorgoglione, Roberta Seccia, Amer Ahmed, Angelo Vozza, Loredana Capobianco, Alessia Lodi, Federica Marra, Eleonora Paradies, Luigi Palmieri, Vincenzo Coppola, Vincenza Dolce, Giuseppe Fiermonte

Summary: The human mitochondrial carrier family (MCF) consists of 53 members, with approximately one-fifth of them still lacking functional characterization. Most mitochondrial transporters have been studied by reconstituting the expressed protein into liposomes and performing transport assays. However, the availability of radiolabeled substrates limits the efficacy of this experimental approach. In this study, a yeast cell model was developed to identify the hypothetical mammalian mitochondrial N-acetylglutamate (NAG) transporter.

BIOMOLECULES (2023)

Article Biochemistry & Molecular Biology

A novel auxin-inducible degron system for rapid, cell cycle-specific targeted proteolysis

Marina Capece, Anna Tessari, Joseph Mills, Gian Luca Rampioni Vinciguerra, Darian Louke, Chenyu Lin, Bryan K. McElwain, Wayne O. Miles, Vincenzo Coppola, Alexander E. Davies, Dario Palmieri, Carlo M. Croce

Summary: The discrimination of protein biological functions in different phases of the cell cycle is limited by current experimental approaches. The article introduces a new AID system, which combines cell synchronization techniques to down regulate protein levels in specific cell cycle phases for studying the differential roles of target proteins.

CELL DEATH AND DIFFERENTIATION (2023)

Meeting Abstract Oncology

Evaluating a rare t(X;14)(q28;q32) translocation reveals MTCP1 as a driving factor in chronic lymphocytic leukemia.

Janek S. Walker, Zachary A. Hing, Steven Sher, James Cronin, Katie Williams, Bonnie Harrington, Jordan N. Skinner, Casey B. Cempre, Charles T. Gregory, Max Yano, Larry P. Beaver, Brandi R. Walker, Jadwiga M. Labanowska, Nyla A. Heerema, Krzysztof Mrozek, Jennifer A. Woyach, Amy S. Ruppert, Amy Lehman, Hatice Gulcin Ozer, Vincenzo Coppola, John C. Byrd, James S. Blachly, Rosa Lapalombella

CANCER RESEARCH (2021)

暂无数据